Nuclear Medicine

Uzm. Dr. Göksel Alçın

Doctor and researcher İstanbul Eğitim Araştırma Hastanesi İstanbul
Breast NeoplasmsProstatic NeoplasmsAdenocarcinomaKidney NeoplasmsStomach Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Prostatic Neoplasms 7 publications
  • Adenocarcinoma 3 publications
  • Kidney Neoplasms 2 publications
  • Stomach Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinesaglik.gov.trFrom source
  • Institutionİstanbul Eğitim Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 7 publications · Model version —From source
  • Publications68 publicationsOpenAlex, Europe PMC, ORCIDFrom source
  • ORCID0000-0003-2268-9606ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://istanbuleah.saglik.gov.tr/TR-1039814/doktorlar.html#goksel-alcinsaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

68 publications

  1. Physiological differences in bone uptake of [99mTc]Tc-pyrophosphate in men and women undergoing cardiac scintigraphy

    Journal of Nuclear Cardiology, 2026

    DOI 10.1016/j.nuclcard.2026.102654 PMID 41655808 1 citation (Europe PMC) Source: OpenAlex

  2. Diagnostic Performance of 68 Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions

    Clinical nuclear medicine, 2026

    DOI 10.1097/rlu.0000000000006405 PMID 41941246 Source: Europe PMC

  3. Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer

    Clinical nuclear medicine, 2026

    DOI 10.1097/rlu.0000000000006582 PMID 42305081 Open-access full textSource: Europe PMC

  4. Comparative Performance of 68Ga-FAPI-04 and 18F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis

    World Journal of Nuclear Medicine, 2026

    DOI 10.1055/s-0046-1819631 PMID 42077575 Open-access full textSource: OpenAlex

  5. Classification of malignant/benign groups in lung cancer by machine learning and investigation of feature significance of parameters

    Biomedical Engineering / Biomedizinische Technik, 2026

    DOI 10.1515/bmt-2024-0628 PMID 42504941 Open-access full textSource: ORCID

  6. Detección mediante PET/TC con 18F-FDG de una metástasis extremadamente rara de cáncer testicular al duodeno

    Revista Española de Medicina Nuclear e Imagen Molecular, 2026

    DOI 10.1016/j.remn.2025.500230 Source: ORCID

  7. Is There a Role of FAPI Pet in Renal and Bladder Cancer?

    Seminars in Nuclear Medicine, 2026

    DOI 10.1053/j.semnuclmed.2025.11.003 PMID 41330807 Source: ORCID

  8. Machine learning–assisted classification of lung cancer: the role of sarcopenia, inflammatory biomarkers, and PET/CT anatomical-metabolic parameters

    Physical and Engineering Sciences in Medicine, 2026

    DOI 10.1007/s13246-025-01650-x PMID 41051469 Source: ORCID

  9. Dedifferentiated Liposarcoma: Two Case Reports of Retroperitoneal and Paratesticular Presentations with FDG PET/CT Findings

    Molecular Oncologic Imaging, 2026

    DOI 10.71286/moi.1794676 Open-access full textSource: ORCID

  10. Incidental Detection of FDG-Avid Pulmonary Lesion on PET/CT in a Patient Referred for Hepatic Lesion Evaluation: Chronic Granulomatous Disease Mimicking Malignancy

    Molecular Oncologic Imaging, 2026

    DOI 10.71286/moi.1744459 Open-access full textSource: ORCID

View all 68 publications